PHM
64
-2
KLAC
57
4
OI
38
-4
HP
52
2
UNP
56
-3
APA
30
3
SO
62
-2
ED
53
-2
PRGO
40
-3
ISRG
73
2
VNO
54
-11
PNW
67
-3
KMI
67
4
DUK
62
-2
CHRW
42
-12
NVDA
54
2
HCP
62
2
MMM
42
2
EIX
77
-3
NWL
56
2
PHM
64
-2
KLAC
57
4
OI
38
-4
HP
52
2
UNP
56
-3
APA
30
3
SO
62
-2
ED
53
-2
PRGO
40
-3
ISRG
73
2
VNO
54
-11
PNW
67
-3
KMI
67
4
DUK
62
-2
CHRW
42
-12
NVDA
54
2
HCP
62
2
MMM
42
2
EIX
77
-3
NWL
56
2
Financhill
Back

GABELLI CONVERTIBLE & INCOME SECURITIES FUND Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
48

GCV
GABELLI CONVERTIBLE & INCOME SECURITIES FUND

Last Price:
4.01
Seasonality Move:
2.83%
Sell
25

DRUG
Bright Minds Biosciences

Last Price:
47.31
Seasonality Move:
-15.89%
Sell
48
GABELLI CONVERTIBLE & INCOME SECURITIES FUND (GCV) is a Sell

Is GABELLI CONVERTIBLE & INCOME SECURITIES FUND a Buy, Sell or Hold?

  • The current GABELLI CONVERTIBLE & INCOME SECURITIES FUND [GCV] share price is $4.03. The Score for GCV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • GCV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GCV Stock Price Chart

What is GABELLI CONVERTIBLE & INCOME SECURITIES FUND's stock price today?

  • The GABELLI CONVERTIBLE & INCOME SECURITIES FUND share price today is $4.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GCV is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $44.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

GCV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 68.22 Buy
Chaikin Money Flow: 44594 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.72 - 3.96) Buy
Bollinger Bands (100): (3.66 - 3.94) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.5 Buy
Relative Strength Index (14 RSI): 58.93 Buy
Chaikin Money Flow: 115403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.12 - 49.42) Buy
Bollinger Bands (100): (-5.11 - 34.85) Buy

GCV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.99 Buy
20-day SMA: 3.88 Buy
50-day SMA: 3.78 Buy
200-day SMA: 3.71 Buy
8-day EMA: 3.98 Buy
20-day EMA: 3.9 Buy
50-day EMA: 3.84 Buy
200-day EMA: 3.78 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.17 Buy
20-day SMA: 42.3 Buy
50-day SMA: 28.61 Buy
200-day SMA: 8.06 Buy
8-day EMA: 39.27 Buy
20-day EMA: 39.13 Buy
50-day EMA: 31.07 Buy
200-day EMA: 12.97 Buy

GABELLI CONVERTIBLE & INCOME SECURITIES FUND Earnings Growth & GCV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

GABELLI CONVERTIBLE & INCOME SECURITIES FUND Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):